Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06481592 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Last Updated on CT.gov | October 30, 2025 (Oct 30, 2025) |
As of March 2, 2026: Clinical trial NCT06481592 is currently recruiting participants. This clinical trial study for endometrial cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Iovance Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06481592 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06481592 was last updated Oct 30, 2025 (October 30, 2025). HelloStudys verifies this status automatically.